Visions Magazine 02 - Bausch + Lomb | See Better. Live Better.

B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 1001
Summer 08/Issue 02
Celebrating a decade
of Akreos® IOL
B&L’s vision aids
British Blind Sport
The Science of
Compliance
A helping hand
- macular
degeneration
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 02
02
Dear Colleagues
Good eye health does not just happen by
itself. It is the result of an important and
ongoing process of informing patients and
consumers about the importance of
compliance. This includes following the advice
of their eye care professional and the
instructions that accompany the product, to
ensure the best possible eye health and
quality of vision.
Good hygiene and using contact lenses and
related products in the intended way may seem
obvious to us, but two new European studies
(led by Dr. Philip Morgan) show that many
wearers handle their lenses incorrectly. Not
washing hands, not cleaning or changing lens
cases, using solutions that are out of date and
wearing the lenses longer than they are
intended for, are examples of actions that put
contact lens wearers at risk of infection.
Unfortunately, these practices are all a lot more
common than we might think. We discuss these
compliance issues in our section on Health.
I am very pleased to announce the 10th
birthday of the Akreos range of intraocular
lenses. The Akreos Micro Incision lens builds on
a platform of 10 years of development within
the Akreos® range. The latest edition to the
range - the Akreos Micro Incision Lens - has
just received a major design award. Read more
in our Science and Technology section, about
how this innovative lens was designed
specifically for implantation through a 1.8mm
micro incision.
®
®
“Significant investment
will increase our
capability to provide you
with the best possible
service as our business
continues to grow”
®
As the manufacturer of a very comprehensive
range of eye care products, we currently make
over 3 million annual shipments, to over 50,000
customers, in Europe alone. These orders can
range from a single contact lens to large pieces
of capital equipment. In order to further improve
the speed, reliability and accuracy of our
deliveries to you, we will, later this year, be
introducing a new state-of-the-art and highly
automated system, at our European Logistics
Centre (ELC), near Schipol airport in the
Netherlands. This significant investment will allow
us to further improve the efficiency and capacity
of our operations, so that we will have the
ongoing capability to provide you with the best
possible service as our business continues to
grow. We will provide you with updates on this
“Best Box” project in future editions of “Visions”.
We had some very positive feedback from our
first edition of “Visions” in April and our goal
is to continue to provide you with interesting
and relevant articles. We would very much
welcome your input and ideas regarding the
content of future editions. Please send all
comments, suggestions and requests for further
information to the editor, Jill Collishaw, at
jill.collishaw@bausch.com
Best regards
Gareth Steer, General Manager
UK, Nordics, Netherlands
Inside this issue at a glance...
NEW PRODUCTS
HEALTH
What’s new for
Summer 2008
The Science of
Compliance 2008
SCIENCE &
TECHNOLOGY
10 years of
Akreos® IOL
EDUCATION
B&L IN FOCUS
Vision Care
Academy what's next?
Stellaris® goes
mobile
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 03
NEW PRODUCTS
03
New Products
New HyperDk GP lenses
from Bausch & Lomb
Bausch & Lomb have recently launched their
new HyperDk GP contact lenses (manufactured
at our Madden & Layman laboratory in
Hastings, UK). These lenses under the
Quantum™ 141 and Maxim™ 141 brands utilise
the new Boston XO2 material developed by
Bausch & Lomb which boasts a HyperDk
value of 141.
Zyoptix® 217z100 Laser
System with Advanced
Control Eyetracking
(ACE) technology
• More accurate and predictable treatments
• Lower total remaining higher order aberrations
• Enhanced outcomes
• Greater patient satisfaction
Now new technology captures ACE Dynamic
Rotational Eye Movement for more accurate
and predictable outcomes. Increasing accuracy
of all Zyoptix® treatments for more predictable
visual outcomes
• Reducing total remaining higher order
aberrations from any variation in treatment
alignment due to eye rotation
• Lowering re-treatments due to under
correction of astigmatism
The new Quantum™ 141 and Maxim™ 141
ranges provide excellent wetting characteristics,
deposit resistance, stability and visual acuity of
the existing high Dk lenses while providing
substantially more transmissibility. Quantum™
141 will be offered in single vision and
presbyopic designs and Maxim™ 141 will be
available in standard Maxim™, Maxim™ Ultra,
Varifocal and Toric. These lenses are available
with UV blocker and in blue or green tint.
Introducing
ReNu® MultiPlus
It also...
• Actively tracks X & Y axis with a response
time of 6.6ms
• Monitors Z axis for correct position
• Adjusts automatically for cyclotorsion from
upright to supine position
• Adjusts for pupil shift if pharmacologic
dilation is required
ACE with Dynamic Compensation for intraoperative
Rotational Eye movement versus non active
rotational tracking. Ablations simulated in plastic.
With ReNu® MultiPlus Multi-Purpose
solution you can have Fresh Lens
Comfort everyday.
It is the only multi-purpose solution
that contains HYDRANATE®, a clinically
proven ingredient that removes protein
deposits while you clean your lenses.
Giving you exceptional cleaning,
ReNu® MultiPlus offers superior
disinfection against a broad range of
micro-organisms to help ensure your
patients are compliant with lens care.
Simulation of effect based on an average of 5
degrees of intraoperative rotational eye movement
Visions 2 no Lotemax:Layout 1
30/6/08
09:30
Page 1
NEW PRODUCTS
1
New Products continued...
Stellaris®
NEW on
screen live
surgery
The Stellaris® Multimedia Centre
The Multimedia Centre (MMC) empowers easy
visualisation of critical surgical parameters on
the Stellaris® Vision Enhancement System.
This increases the safety and efficiency of your
operating theatre as nursing staff know at all
times how the surgical case is progressing
without the need for a separate monitor and
you are able to review your machine settings
case-by-case after the list has ended. The MMC
does this by both inlaying live microscope
footage to the High Definition Touch Screen of
the Stellaris® and overlaying settings onto
microscope footage of each case recorded to an
external device.
Every new Stellaris® purchased comes with this
technology as standard. Ask your local Surgical
Equipment Specialist for more details.
Have you noticed the difference with
PureVision® spherical contact lenses?
High Definition Vision now feels more comfortable
with the redesigned anterior lens surface, giving
PureVision® spherical contact lenses a much
smoother surface. The greatest significant
improvement in comfort rated was at the end of
day , which is a key consideration when making
the decision on what lens to select for a patient.
There were also significant improvements in
comfort upon insertion and at 4 hours .
1
With these beneficial enhancements,
PureVision® still delivers the same exceptional
visual performance. High Definition Vision is
delivered through an aspheric anterior surface
lens design, which controls spherical aberration
and has been clinically proven to improve vision,
especially in low-light conditions when it often
matters most.
1
As a result PureVision® now offers a consistently
lower modulus for softer lenses without changing
the oxygen transmissibility.
REFERENCES
1.
2.
2,3
Additionally, there are two base curves – 8.6 and
8.3, to give more fitting options.
3.
4.
Bausch & Lomb Clinical Research report, November 2006 (data on file).
2005/2006 comparison of improved PureVision SVS lenses and PureVision SVS lenses shipped before
April 2007, Bausch & Lomb.
Ghormley NR. How Modulus Affects Contact Lenses. Contact Lens Spectrum, November 2005.
These simulated retinal images represent the effects of correcting +0.15 Ìm of spherical aberration
over a 6 mm pupil (population average) [Thibos LN, et al. J Opt Soc Am A. 2002; 19:2329 2348]. The
highlighted objects (car or runner) at a distance of 1,000 feet and each subtending 20 minutes of arc,
which corresponds to the region of highest acuity in the human eye foveal region. Individual results
may vary. [Westheimer G., Visual Acuity. Chapter 17. In: Moses, R. A. and Hart, W. M. (ed) Adler’s
Physiology of the eye, Clinical Application. St. Louis: The C. V. Mosby Company, 1987].
Without aspheric optics4
With PureVision® aspheric optics4
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 05
HEALTH
05
Bausch & Lomb’s vision
aids British Blind Sport
We are excited to announce that we have
selected British Blind Sport as one of our
new charities.
British Blind Sport focuses on encouraging the
active participation of visually impaired people
(especially youth) in a large range of sporting
events. The participants could be either partially
sighted or blind and participate in events
ranging from archery, shooting, cricket, football
and goalball (a sport specifically designed for
the visually impaired which has sporting
equipment adapted to allow the participants to
utilise other sensory functions to guide them).
At present British Blind Sport is still a small
charity, but does work on a national level, utilising
the skill of sports coaches on a voluntary basis.
One such event is the Partially Sighted Football
League which consists of eleven 5-a-side teams
that follow the new international rules for Futsal.
Interestingly, some of the players in the league also
play internationally for the England Partially Sighted
Team. The totally blind Great Britain team will be
going to Beijing to attend the Paralympic Games.
Bausch & Lomb are proud to sponsor the football
season and we attended our first event the
Visually Impaired Futsal League Season Finale held
on Saturday 26th April 2008 at the Telford Dome.
It had been a long six week break since league
tournament 5, with the leaders in both Divisions 1
and 2 enjoying healthy gaps to their nearest rivals.
The battles seemed to focus on the race for
second place in both Divisions, and the anticipated
relegation scrap for one of the longest serving
clubs within Division 1.
Inter Cosmos, who boast England players within
the team had, it would seem, a straightforward
task to avoid relegation. Bottom of the league at
the start of proceedings (due mainly to England
training clashing with earlier tournaments) they
simply had to score more points than
Loughborough B team. Things did not start well.
Defeats to Loughborough A team, West Bromwich
Albion and RNC put an end to any hope Cosmos
might have had of getting out of trouble. After
over a decade in the top flight of VI football Inter
Cosmos had been relegated and must now
contemplate second division football.
Pictured left is Gareth Steer from Bausch & Lomb
presenting the ‘Player of the Year’ trophy to John
McDougal from West Bromwich Albion, the proud
winners of Division 1.
British Blind Sport (BBS) is a national registered charity (Registered charity
number 271500) based in Leamington Spa. Since its beginnings as a registered
charity in 1976, British Blind Sport has become the leading voice for visually
Futsal is an indoor version of
association football. Its name is derived
from the Portuguese futebol de salão and
the Spanish fútbol sala/de salón, which
can be translated as 'indoor football'.
Futsal is played between two teams of
five players, one of whom is the
goalkeeper. In addition each team may
have 7 substitutes. Unlike some other
forms of indoor football, the court is
delimited by lines, and not walls or
boards that players can use to rebound
the ball. Futsal is played with a smaller
ball with less bounce than a football.
The emphasis is on improvisation,
creativity and technique.
We look forward to attending the Pre-Season Cup
in October 2008, this will be renamed the ‘Bausch
& Lomb Pre-Season Cup’.
“Player of the Year
trophy went to
John McDougal from
West Bromwich Albion,
the proud winners
of Division 1.”
impaired people (VI) in the world of sport and leisure, both at home and
internationally. British Blind Sport needs to raise a minimum of £300,000 per
annum towards its activities; this is achieved through the efforts of a small
fundraising team and the members themselves. The charity receives no regular
funding and depends entirely on donations from companies, charitable trusts and
foundations and individuals. Donations to support BBS work can be made via
Tel 01926 424247 or www.britishblindsport.org.uk
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 06
HEALTH
06
A helping hand
The Macular Disease Society is a UK based charity and the only
one dedicated to helping people with macular degeneration.
Being diagnosed with macular degeneration
can be a frightening and lonely time, which
makes the work of the Macular Disease Society
so valuable to patients and their families.
The society aims to build confidence and
independence for those with central vision
impairment, offering advice and practical
support to sufferers who otherwise may
struggle to come to terms with their condition.
From helpline advice to research, the Macular
Disease Society lends a supportive hand to help
those affected make the most of their vision,
and Bausch & Lomb are a proud supporter of
their work.
A Helping Hand
Helpline
The Society runs a helpline for all patients and
their families 0845 241 2041 offering advice on
the practical impact of life after diagnosis with
MD such as new treatments and accessing
social care.
Counselling
A telephone counselling service run by trustee
and macular degeneration sufferer Dennis Lewis,
is available to help patients come to terms with
their condition.
The Society is in the process of setting up a
network of Community Support Desks which are
located in libraries and other public places, and
provide a chance for recently diagnosed
patients to discuss their concerns.
Information
Members of the Society receive ‘Side View’
a quarterly magazine, with information on the
latest developments in macular degeneration
research and news.
Local Groups
The Society runs a national network of 150
Local Groups which give members a chance
to meet other sufferers and share advice and
guidance. On joining the Society, members are
invited to join their nearest group.
There are separate groups for working age
members, which give support in the field of
training, job retention and technology for the
visually impaired at work.
Hospital Support
In Leicester Royal Infirmary and Mayday Hospital
Croydon, Macular Disease Society volunteers
attend on macular clinic days to ensure that
newly diagnosed patients have a point of
contact for help and support.
‘Age-related macular degeneration (AMD) causes
severe visual loss and is the commonest cause of
blindness in persons >50 years old in the western world.
Two main forms of AMD occur: dry and wet.
The dry form accounts for 90%, whilst the wet form occurs
in 10% of all AMD….There is, unfortunately, no medical or
surgical treatment currently available for dry AMD…
Ocular nutritional supplements have been shown
(in the AREDS Study) to slow the progression of
dry AMD to more advanced stages.
Such nutritional supplements should therefore be
recommended to patients.’
Research
The Society actively promotes research into
macular degeneration by funding research
projects at UK hospitals.
Several conferences are held each year at
various locations around the UK to enable
members to hear the latest developments
from acknowledged experts in the field.
The Society donated £147,000 in 2007 to research
into the causes of macular degeneration. Details of
past research projects can be viewed at
www.maculardisease.org.
The society aims to
build confidence and
independence for those
with central vision
impairment, offering
advice and practical
support to sufferers who
otherwise may struggle
to come to terms with
their condition.
(AMD Interim Guidelines: The Royal College of
Ophthalmologists Interim Recommendations
for the Management of Patients with
Age-related Macular Degeneration)
The Age-Related Eye Disease Study (AREDS)
(Arch Ophthalmology, Oct. 2001) was
conducted over 10 years by the National Eye
Institute in the USA with 4757 participants.
The high-dose supplement formulation of
vitamins C, E, beta-carotene and zinc which
was tested in this study was found to reduce
the risk of progression to advanced AMD by
25% and reduce the risk of visual acuity loss
by 19% for patients with moderate to
advanced AMD.
The supplement used in this study was
provided by Bausch & Lomb and is now
available in the UK under the brand name
®
‘PreserVision ’.
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 07
HEALTH
07
PATIENT EDUCATION EVENTS
SUPPORT AND GUIDANCE
Bausch & Lomb are proud to support the
Macular Disease Society’s forthcoming
patient education event. This event has a
varied programme of talks, with
ophthalmologists and health care
professionals as speakers, and provides an
opportunity for patients to meet and share
their experiences:
To give your patients access to continued
support and guidance outside your clinic,
you may refer patients diagnosed with
macular disease to the Macular Disease
Society. To join, patients can register online
www.maculardisease.org or contact the
Macular Disease Society as follows:
Saturday 20th September 2008
Royal National Hotel
Russell Square
London, WC1H 0DG
The Macular Disease Society
PO Box 1870
Andover
Hants, SP10 9AD
Registered Charity No. 1001198
Tel: 01264 350551
Fax: 01264 350558
email: info@maculardisease.org
Several conferences
are held each year at
various locations around
the UK to enable
members to hear the
latest developments
from acknowledged
experts in the field.
The Society donated
£147,000 in 2007 to
research into the causes
of macular degeneration.
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 08
HEALTH
08
The Science of Compliance
Research uncovers the truth about consumers’ attitudes and
behaviours towards contact lens compliance.
It is widely acknowledged that
consumers are not compliant. In
2007 Bausch & Lomb commissioned
research conducted by Dr Philip B.
Morgan, PhD MCOptom FAAO FBCLA
across seven European countries and
1,400 contact lens wearers to uncover
the truth about patient attitudes
and behaviour towards lens wear
and care.
UK EYEGIENE RESULTS SURVEY
Correct solution
Advised received
Replace solution
Handwashing
Shockingly, the research highlighted the true
lack of consumer adherence to compliance,
with 98% of all contact lens wearers being
non-compliant in at least one aspect of their
care regimen. The findings published in ‘The
Science of Compliance’ quantified the real
risks, and Bausch & Lomb is now using this
data to endorse our campaign for GREEN
BEHAVIOUR – a response considered to be
wholly compliant.
Hands up for Eyegiene™
Over the years a number of studies have
shown a link between inadequate contact lens
care and ocular infection.
Infections occur most commonly as a result of
direct contact between individuals (person-toperson transmission). It was disturbing then to
find, that the results from the research found
UK patients to be the worst nation for handwashing, with only, just over half (56%) of UK
contact lens wearers washing their hands
before inserting lenses and only 14% always
washing their hands before removing lenses.
Evidence from the use of hand washes in
hospitals confirms that an element of training
in the best methods is required. Hands should
be washed with soap, antiseptic liquids or
wipes and dried with a lint free towel prior to
touching the eye.
The verdict on the case
An important outcome of the research is that
case care is often over looked by lens
wearers, and can ultimately result in an
increase of the bioburden at the ocular
surface during contact lens wear.
Furthermore, the development of microbial
biofilms in contact lens cases can reduce the
Sleep in lenses?
Correct replacement
Rinsing and rubbing
Change case
Clean case
5
4
3
2
0
1
Relative risk
20%
40%
60%
80%
100%
% Non compliance
Figure 1 Relative risks and non-compliance for a range of compliance and usage factors. Data for
use of correct solution and unscheduled sleeping in lenses for microbial keratitis.27 Data for receipt
of advice and lens cleaning for Acanthaamoeba keratitis.29 Data for replacing all solution and
handwashing for Fusariam keratitis and microbial keratitis.16 Data for correct lens replacement for
Fusarium keratitis.19 Data for case care from for microbial keratitis.21
effect of a disinfecting solution – an important
consideration when we find only 10% of
wearers have adopted ideal practice and used
a new case every month (or more frequently).
We still need to reinforce the importance of
cleaning cases on a daily basis – with the
appropriate solution and leaving the case to
air dry. The research found, of those that did
clean their lens case, only a third of wearers
(34%) cleaned their cases with contact lens
solution. The case should be changed at least
once a month. When you take all these steps
of lens case compliance into consideration,
the results from the research showed that
79% of lens wearers are non-compliant when
it comes to the care of the case.
To continue to educate ECPs on the importance
of compliance, Bausch & Lomb have created
‘The Science of Compliance – A Guide for Eye
Care Professionals’ training CD. A training CD
featuring Dr Philip Morgan and approved with 2
CET points. The presentation is based around the
results of ‘The Science of Compliance’ and
reports on the increased bioburden and
decreased ocular defence mechanisms, which
occurs during contact lens wear and which
specific risk factors have been linked to contact
lens associated keratitis.
Shockingly, the research
highlighted the true lack
of consumer adherence
to compliance, with
98% of all contact lens
wearers being noncompliant in at least
one aspect of their
care regimen.
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 09
HEALTH
“Ultimately every
eye care professional
wants a confident
partnership with their
patients in order to
establish mutual
understanding and
goodwill that will
result in optimum
ocular health.”
‘If we, as contact lens practitioners, can
understand both the real life behaviour of our
patients and the perceptions they have about
caring for their contact lenses, we can
communicate better with them, and optimise
their use of both contact lenses and care
systems’ advises Morgan.
Dr Philip Morgan concludes from the report,
‘ultimately every eye care professional wants a
confident partnership with their patients in order
to establish mutual understanding and goodwill
that will result in optimum ocular health’.
Bausch & Lomb is supporting the profession,
helping to educate patients about compliance
with a set of tools for the practice Eye Care
assistants and front-line staff can also play a
vital role in using these tools during the
fitting session.
09
QUESTION ?
GREEN RESPONSE
RED RESPONSE
How many days do you wear your
lenses before throwing them out?
As recommended for lense type
More than 10% extra
How often do you sleep
in your lenses?
As advised by practitioner or less
More than advised
Do you nap in your lenses?
Never
Some napping in lenses
Do you wash your hands
before inserting and removing
and what with?
Always wash hands with soap,
antiseptic liquid or wipes
Not always washing hands
What do you use to clean/store
your contact lenses?
Multipurpose/Hydrogen Peroxide
(& cleanser and/or Saline)
Saline only/any water or
saliva/leanser - protein only
Where do you store
your contact lenses?
In a lense case
In a mug/glass
Do you replace your
solution or top up?
Always replacing all solution
in the lense case
At least sometimes topping up
Do you cover your contact
lenses completly?
Always
Less frequently
Do you close your lenses
case tightly?
Always
Less frequently
Do you clean your case?
Everyday with solution
Without solution or less
often than once a week
How often do you
change your case?
Monthly
Anything worse
Do you close the cap of
your bottle tightly?
Yes - always
Anything worse
Do you ever check the expiry
date of your solution bottle?
Yes - regularly
Less frequently
Do you ever share your contact
lense case with other people?
Never
At least sometimes
Figure 2
THE SCIENCE OF COMPLIANCE – A GUIDE FOR EYE CARE PROFESSIONALS
– the full findings from the research.
To order any support materials of for more
information, please call Bausch & Lomb VisionCare
customer services on: 0845 602 2350.
PATIENT RECOMMENDED CONTACT LENS REGIMEN TEAR SHEETS – Bausch & Lomb can provide
the practice with patient tear sheets describing best practice for healthy contact lens care.
Straight forward steps to contact lens wear and care success, this sheet is intended for patients
and professionals to talk through the recommended regimen and for patients to take away
as a reference.
PRACTICE POSTER – Poster available highlighting the traffic light model measures.
The list of key questions will help you run through the key check list with patients
during check-ups giving them the red or green approval.
HEALTHY CONTACT LENS CARE KIT – contains everything your patients need for healthy contact lens wear.
The kit contains:
• 3 x 240ml ReNu® MPS™ (3 months supply) • 1 x 120ml ReNu® MPS™ (for travelling)
• 4 x Contact Lens cases (to be compliant)
• 1 x Healthy Contact Lens Care Programme leaflet
• 1 x Mini tote bag that contains a towel
so they can wash their hands anywhere, anytime, before handling their contact lenses
Dr Philip Morgan, PhD MCOptom FAAO FBCLA
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 10
HEALTH
10
Celebration – a decade
®
of the Akreos IOL
In order to meet the increasing demands of surgeons, intraocular lens
design has gone through numerous changes over the last few decades.
BAUSCH & LOMB WINS GOLD IN
THE MEDICAL DESIGN EXCELLENCE
AWARDS COMPETITION
Akreos® AO Micro Incision intraocular lens
receives a prestigious honour.
Figure 1
These developments have resulted in high
quality lenses that are completely tolerated,
stable in the eye, PCO free and have excellent
quality of vision. Now that the growing trend
is towards MICS™, the boundaries are being
pushed yet further and lens design needs to
be modified again to accommodate this new
requirement.
The first Akreos® intraocular lens (IOL) was
implanted by Pr. Jean-Louis Arné on 29th June
1998 in Toulouse, France. This lens, known as
the Akreos® Disc, was the first of a family of
lenses that have spanned a decade and been
implanted in over 2 million people worldwide.
All disc designs generally stem from the very
first implant made by Harold Ridley on 29th
November 1949 at St Thomas Hospital, London.
These implants are stable but large, so are
unsuitable for small incision surgery.
There have been 5 generations of design in the
Akreos® family (Fig 1); The Akreos® Disc, the
Akreos® Fit and the current family trio which
consists of the Akreos® Adapt, Akreos® AO and
the new Akreos® MI60 Micro Incision lens.
The Akreos® MI60 lens, like its Akreos®
predecessors, is composed of a biocompatible,
hydrophilic acrylic material, which makes it
incredibly strong yet flexible enough to be
inserted through a 1.8mm incision.
The material for this range of lenses was first
developed in 1996-1997. It is a copolymer of
HEMA (hydroxyethlmethacrylate) and PMMA
(polymethylmethacrylate). These polymers
have a long record of use in ophthalmology
and demonstrate excellent biocompatibility.
PMMA has been used in IOLs since the 1960s,
whilst HEMA is used both extraocularly in
The Akreos® AO Micro Incision lens (Akreos®
MI60) wins Gold in the 2008 Medical Design
Excellence Award (MDEA), the premier
awards programme for the medical
technology community.
In keeping with Bausch & Lomb’s drive for
smaller cataract incisions and ever better
patient outcomes, the innovative Akreos®
MI60 intraocular lens was designed
specifically for implantation through a
1.8mm incision. It can be inserted through a
micro incision due to its incredibly strong yet
flexible acrylic base material: a unique acrylic
material that has a ten year history of
performance and successful implantation in
more than two million eyes worldwide.
“With the Akreos® MI60 intraocular lens and
the new Stellaris® Vision Enhancement
System, accommodating both 1.8 mm coaxial
and biaxial techniques, Bausch & Lomb is the
only company today that can offer such a
complete solution for micro incision cataract
surgery” said Dr. Joel Pynson, Director of
design engineering who led the Akreos®
MI60 project team.
“As part of our innovative, industry-leading lens
portfolio the Akreos® MI60 provides surgeons
with options that deliver the outcomes their
patients demand,” said Alan Farnsworth,
Corporate Vice President and President, Europe,
Middle East and Africa region.
Please visit www.micsplatform.com for
more information.
Figure 2
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 11
HEALTH
11
sub-2mm, but without jeopardising the desired
lens performance of optical quality, stability and
low PCO (as associated with the parent design,
the Akreos® Adapt AO).
The Akreos® MI60 lens is 30% thinner than its
parent the Akreos® AO allowing implantation
through a sub-2mm incision.
Figure 3
contact lenses and intraocularly for scleral
implants. The hydrophilic component, HEMA,
allows the lens to be easily compressed to fit
through a micro-incision and unfold smoothly
when implanted in the eye. The mechanical
resistance of the hydrophobic acrylic component
(MMA) ensures the lens recovers its initial shape
without damage.
With the need for a lens suitable for MICS™, the
engineers at Bausch & Lomb were faced with the
challenge of producing a lens compatible with
The novel haptic design is slender, but ensures
excellent stability of the implant. The external
portions of the haptics, known as the absorption
zone, undergoes deformation in 3 dimensions in
order to limit any pressure which may be exerted
on the optic (Fig 2).
The base of the haptics is rigid and thicker, and together
with the optic, forms the foundation zone (Fig 2).
The Akreos® MI60 lens uses the same anti-PCO
properties of the Akreos® AO: the 360º anti-PCO
barrier and square edge design (Fig 3). The haptics
on the new lens known as the Conforming Tips (Fig
2) are also angled at 10º to improve contact with
the posterior capsule.
Like its predecessor, the lens uses an aberrationfree aspheric optic. This leaves the eye with its
natural degree of corneal positive spherical
aberrations, improving contrast sensitivity and
benefiting patients with good depth of field.
The Akreos® AO Micro Incision intraocular lens
(Akreos® MI60) wins Gold in the 2008 Medical Design
Excellence Award (MDEA), the premier awards
programme for the medical technology community.
To find out more about the Akreos® AO Micro Incision lens, Bausch & Lomb UK
have the pleasure in announcing two MICS™ symposia to be held in October 2008.
Please see the invitation below.
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 12
SCIENCE AND TECHNOLOGY
12
Seeing is believing
From the age of eight, PA Rebecca Martin, needed to wear glasses
every day, and they made her feel terribly self-conscious, but
without them, the world was a blur.
Mr Pillai says Zyoptix® has other advantages
over standard laser surgery, “After traditional
laser surgery, although good sight usually
resulted, patients would complain of night halos
and night vision problems. Zyoptix® has virtually
eliminated these.”
Zyoptix® technology falls into three categories.
First, there is Wavefront treatment which is
particularly suitable for patients that have large
pupils and for all prescription types. It is also
used to eliminate night vision problems which
can occur with standard laser treatment.
The second category is tissue-saving treatment,
used when someone has a thin cornea, as the
procedure removes less tissue.
Rebecca Martin, Before Zyoptix®
Rebecca Martin, After Zyoptix®
Today, however, she has perfect
vision, and it’s all thanks to Zyoptix®,
the new laser vision correction surgery
technology, pioneered by Bausch
& Lomb.
Rebecca’s optometrist researched her options
and found out that Bausch & Lomb had
developed a new type of laser eye surgery
technology, called Zyoptix®, which offers a
solution for people like Rebecca, who need
a personalised vision treatment. Now, even
people with high prescriptions, large pupils
and/or thin corneas can have their vision
restored.
Rebecca, 23, who comes from Surrey, endured
taunts of ‘foureyes’ when she was at primary
school. “If I put my glasses on, it would
remind me of the bullying I received as a child
and subsequent lack of confidence, which in
turn affected my work.” She recalls. “There
were all these gorgeous trendy glasses out
there, but I just couldn’t take advantage of
them. I was so hung up I didn’t even like my
fiancé Mike to see me wearing them.”
“Having to wear vision correction aids spoilt my
leisure time too. I go swimming every day, and
you can’t wear glasses in the water. Without
them I was blind as a bat, I could barely see the
side of the pool.”
Rebecca despaired. Not only was she extremely
shortsighted, but, like many people with blonde
hair and blue eyes, she also has large pupils.
She was told that the combination of these
factors made her unsuitable for conventional
laser eye surgery.
“Bausch & Lomb has devised outstanding new
technology for laser surgery,” says Mr CT Pillai,
Consultant Ophthalmic Surgeon and Medical
Director at Advanced VisionCare in Harley
Street, London, one of the 36 Zyoptix® clinics
in the UK.
“Laser surgery used to be performed with
standard technology that treats only the
prescription of the eyes. Patients who had night
vision problems, very high or complicated
prescriptions, thin corneas or large pupils were
simply not suitable. But with Zyoptix®, many
more of these patients can now be treated.
“The new technology employs a faster laser, iris
recognition technology and is programmed to
treat every eye individually according to the
specific needs of the patient.”
Finally, there is the latest Aspheric treatment,
which can be used for patients who are not
found suitable for Wavefront. Aspheric takes
into account the natural shape of the cornea
and designs the treatment around it. Aspheric
is particularly valuable for patients with high
prescriptions, large pupils and thin corneas.
According to Mr Pillai, this saves corneal
tissue, eliminates night vision problems and,
most importantly, unlike every other laser
treatment option, it does not alter the natural
shape of the cornea.
“After traditional
laser surgery,
although good
sight usually
resulted, patients
would complain of
night halos and
night vision
problems. Zyoptix®
has virtually
eliminated these.”
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 13
SCIENCE AND TECHNOLOGY
13
Aspheric Treatment
Three months ago, Rebecca underwent
aspheric treatment to correct her eyesight.
“It was slightly more expensive than the high street laser surgery I’d seen advertised, but
I knew I was getting the best, safest and most up-todate technology, and that I’d be in the
hands of a highly trained and reputable surgeon.” says Rebecca.
Mike says “I was very nervous before the procedure.”
Rebecca recalls “I wouldn’t let go of his hand, but it was completely painless and it was
over very quickly. I think it only took about 15 minutes for each eye.
The first thing I saw was the clock; I could actually read its face clearly without
lenses or glasses. It was the first time I’d been able to do that since I was little
and I felt a bit tearful.
My eyes were a bit sore for a few days and I had to use steroid drops for a week, but
they have now fully recovered. My eyesight is 20/20 in one eye and 20/15 in the other
which is perfect. I don’t even have any problems with glare when I drive at night.
To this day, I can’t believe that I can see without my glasses. I can’t tell you what it means
to me to know that, when I marry Mike later this year, I’ll be able to walk down the aisle
and see his face, and everyone else’s, clearly. I feel confident, attractive and, because I
can now go swimming as often as I like, I feel fitter and more toned too.”
Do you routinely screen for night driving difficulty?
The Zyoptix® Personalised Vision Correction
System has been proved to reduce reports
of night driving difficulty.
The Zyoptix® Personalised Vision Correction
System has been proved to reduce reports of
night driving difficulty. With long winter
nights approaching there is no better time to
ask your prospective LASIK patients about
their comfort level while driving at night.
In a recent US clinical trial of Zyoptix® demonstrated
not only a significant reduction in reports of night
driving difficulty following treatment, but also
showed significant reductions in reports of light
sensitivity, blurring of vision and headaches.
Further, objective vision testing demonstrated that
Zyoptix® treatment significantly improved constrast
sensitivity (CS) under mesopic, or dim light
conditions. In fact, more than one in five cases
showed a dramatic improvement in CS greater than
2 lines. Contrast sensitivity testing helps determine
how well patients see in difficult viewing situations
such as in very dim light, rain, snow or fog.
Why does this matter?
A recent national survey conducted by Road &
Travel magazine identified some important
findings among drivers primarily wearing
glasses or contact lenses:
SYMPTONS REPORTED AS MODERATE,
MARKED OR SEVERE
19%
19%
• Nearly a third (32%) report having significant
difficulty driving in the dark
• Nearly half (48%) report experiencing glare
or light sensitivity while driving in the dark
After Zyoptix®
Before Zyoptix®
12%
7%
10%
7%
• More than two in ten (21%) report blurred
vision while driving in the dark
• Almost two in ten (19%) report experiencing
headaches while driving in the dark
4%
3%
®
So Zyoptix Personalised Laser Vision Correction
is not only about freedom from glasses and
contacts, but also provides better vision when
your patients need it most.
Night Driving
Light
Difficulty
Sensitivity
Blurred
Vision
Headaches
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 14
SCIENCE & TECHNOLOGY
14
Enjoy clarity with freedom
Zyoptix ® Clinics
APPERLEY BRIDGE
Yorkshire Eye Hospital
Telephone: 01274 612566
Website: www.yorkshireeyehospital.co.uk
DUBLIN
The Mater Hospital
Telephone: +35 318384444
Website: www.materprivate.ie
LONDON
Advance VisionCare
Telephone: 0845 051 6464
Website: www.advancevisioncare.co.uk
READING
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
BELFAST
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
EAST GRINSTEAD
Centre for Sight
Telephone: 0700 028 8288
Website: www.centreforsight.com
LONDON Tottenham Court Road
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
SHEFFIELD
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
BIRMINGHAM
Aston University Life Sciences Laser
Institute
Telephone: 0121 204 3800
Website: www.astonacademy.co.uk
EDINBURGH
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
LONDON Hammersmith
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
SOUTHAMPTON
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
GALWAY
Galway Laser Eye Clinic
Telephone: +35 391720070
Website: www.galwayclinic.com
MAIDSTONE
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
SOUTHPORT
Drayton House Clinic
Telephone: 01704 563 279
Website: www.draytonhouseclinic.com
GLASGOW
Ultralase
Telephone: 0808 144 2020.
Website: www.ultralase.com
MANCHESTER
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
St ALBANS
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
GUILDFORD
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
MANCHESTER
Viewpoint Vision Services
Telephone: 0161 848 0811
Website: www.viewpointvision.com
SUNDERLAND
Site for Eyes
Telephone: 0191 528 3616
Website: www.site-for-eyes.co.uk
KETTERING
Woodland Hospital
Telephone: 0845 882 0210
Website: www.ramsayhealth.co.uk
MIDDLESBROUGH
Tees Sight Clinic
Telephone: 01642 222110
Website: www.teessightclinic.co.uk
WATERFORD
Waterford Eye Clinic
Telephone: +35 351874135
Website: www.waterfordeyeclinic.ie
LEEDS
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
NEWCASTLE-UPON-TYNE
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
LIVERPOOL
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
NORTHAMPTON
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
LIMERICK
The Wavefront Eye Laser Clinic
Telephone: +35 3538724966
NOTTINGHAM
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
BIRMINGHAM
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
BRISTOL
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
CARDIFF
MDA Clinic
Telephone: 0292 035 3950
Website: www.mdaclinic.co.uk
CARDIFF
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
CHELMSFORD
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
CHESTER
Ultralase
Telephone: 0808 144 2020
Website: www.ultralase.com
CORK
Shandon Street Hospital
Telephone: +35 3214227800
Website: www.shandonstreethospital.com
To find your local Zyoptix®
clinic go to:
www.bausch.co.uk/en_UK/
consumer/surgical/
findsurgeon.aspx
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 15
EDUCATION
15
Next steps for Bausch & Lomb
Academy of Vision Care™
After the success of the Bausch & Lomb Lectures 2008, what will
be offered next?
March 2008 saw the launch of Bausch & Lomb
Academy of Vision Care™, a new educational
initiative designed to support continuous
learning and development within the eye
health industry.
The success of the Bausch & Lomb Lectures was
evident by the feedback received from delegates:
“Exceeded my expectations. Was happy that we
received an unbiased view of many topics.”
Ms S, Glasgow
“A wide range of topics, well presented. I found
it good to help me think positively about some
issues which I can then relate more positively
to my patients.”
Mrs E, Manchester
“I thoroughly enjoyed all the lectures and
found them very useful. I will be taking away
all the new information I have learnt today
and implementing it in my consulting room.
Well done Bausch & Lomb, I had a fab day!”
Mr S, London
The first programme was the Bausch & Lomb
Lectures 2008. Five 1 day CET events, provided
practitioners with up-to-date, practical and
experience-based lectures and resources that
addressed everyday practice and business
challenges.
Earlier this year, the Optician wrote (April 4th
edition) “…with a wealth of CET events on the
vision care calendar this spring, persuading
large numbers of practitioners to leave their
practices for the day was not going to be an
easy task. Not so in the case of the Bausch &
Lomb Lectures, that saw a total of 1,000
delegates gather at five venues around the UK
in March. The London event attracted more than
300 practitioners and had over 150 delegates
on a waiting list (many of whom travelled
further a field to other venues to attend)…”
“Great to see the industry leader engaging with
the profession this way. We are not in business
together as much as in partnership.”
Mr H, Glasgow
Among many positives, feedback forms
distributed after the lecture series revealed that
they were successful in increasing the confidence
of practitioners in prescribing multifocal contact
lenses for their presbyopic patient base:
The London event
attracted more than
300 practitioners and
had over 150 delegates
on a waiting list.
offer an on-line resource for students,
pre-registrars and support staff along with
on-line CET initiatives for Eye Care Practitioners.
Cheryl Donnelly, Director of Professional Services
& Clinical Affairs said “the website will be the
portal for the educational initiatives from Bausch
& Lomb Academy of Vision Care™, and we
envisage supporting all members of the practice
with articles, on-line lectures, a resource bank
and links to industry websites. It will also serve
as a means of notifying members of the latest
technological and scientific breakthroughs as
well as upcoming CET initiatives.”
To register to become an Academy member,
please visit www.bausch.co.uk
“Before I would always start with monovision
as my 1st choice for presbyopic patients.
But I am now starting to experiment more
with multifocal lenses and to my surprise they
are not as complicated as I thought. I have
confidence in fitting and recommending.”
Mr I.S, London
Overall, the Bausch & Lomb Lectures were a
convincing testament to the commitment that
the Bausch & Lomb Academy of Vision Care™
will provide high quality and professional
education, defining the standard for future
initiatives to come.
We are currently extending an invitation to
practitioners to sign up to become members of
the Academy in anticipation of the launch of
the Bausch & Lomb Academy of Vision Care™
website in early Autumn 2008. The website will
CONGRATULATIONS!
Bausch & Lomb Academy of Vision Care™ would
like to thank all delegates that participated in
The Bausch & Lomb Lecture 2008 evaluation
forms and would like to announce the five
winners of an iPod Shuffle. Each winner will
have been notified individually:
Mr J. Evans • Ms E. Neville • Mr J. Haynes
Ms S. Mascarenhas • Mrs R. Kothari
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 16
EDUCATION
16
Highlights from the 2008
BCLA Clinical Conference
Paper and Poster Review
attend) and improving loyalty in the channel of
trade that patients purchase their contact lenses
and lens care.
Mr Pope explained that in this model there
are 6 proven universal principles of influential
communication and how they can be applied
specifically to the optical practice. This
presentation left practitioners wanting to know
more about the Powers of Persuasion and how
that can enhance several areas in their practice
and what simple and subtle changes can be made
to ensure compliance.
To understand more about these principles, and to
take part in research in using the model in the
optical practice, please e-mail Nick Pope at
eyegiene@bausch.com.
Jerry Ostrov, CEO Bausch & Lomb
This year’s British Contact Lens Associations 32nd
Clinical Conference and Exhibition held in
Birmingham was one of the most successful and
exciting yet for delegates and exhibitors alike.
More than 1,000 attended from 48 countries to
hear about the latest clinical research and
product innovations.
Bausch & Lomb were proud to be the Platinum
Sponsor of the BCLA again during 2008. Jerry
Ostrov, Bausch & Lomb’s Chairman and CEO,
delivered the Platinum Sponsor’s presentation. He
addressed how the vision care markets are once
again ripe for substantial growth and discussed the
factors necessary for this to occur. He further
suggested how manufacturers and practitioners
can better collaborate for increased patient
satisfaction and ultimately grow ECP’s businesses
and the market. Opportunity awaits with the
innovative technologies and products on the
horizon.
Highlights from the 2008 BCLA Clinical Conference
began with the opening session on Thursday
morning; ‘Patient and Practitioner non-compliance
and how to improve it’ a theme that was very
much a hot topic throughout the Conference.
Despite a power failure lasting throughout most of
the morning session, all speakers delivered
excellent lectures captivating the audience despite
no slides or microphones.
The ‘Science of Compliance’ was the session
delivered by Nick Pope, Director of Sales Training
EMEA for Bausch & Lomb. This lecture explored the
powers of influential communication that can
affect our patients’ compliance to practitioner
recommendations. Not just in following contact
lens care and lens replacement instructions, but
related to improving the rate of ‘DNA’ (did not
The dynamics of the eyelids play a tremendous
role in the stabilisation of toric contact lenses.
Craig Josephson delivered a paper to assess high
speed camera technology and motion detection
software in the evaluation and study of blinking
dynamics. The physiological descriptors of the
normal blink reveal important information which
will influence the success of toric lens designs.
Such as the almost entirely horizontal motion of
the lower lid and that it may play only a minimal
role in toric lens stabilisation.
Innovation is key to expanding the market. Ravi
Sharma, a principal scientist of Bausch & Lomb
R&D, discussed antimicrobial silver technology in
contact lenses and lens care. Ravi provided a
review of current ophthalmic product applications,
the methods used to incorporate silver into contact
lenses and the challenges related to this
technology. Will the industry embrace this as the
next step in lens innovation?
Dr Gary Orsborn, Medical Marketing Director
launches SofLens™ daily disposable for
Astigmatism
During the rapid fire session, Dr Mohinder
Merchea, Director of Global Clinical Development,
presented a paper on the first study to evaluate
the relationship between transient corneal staining
after wearing contact lenses soaked in different
multipurpose solutions noting the concentration of 27
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 17
EDUCATION
unique inflammatory markers in the tears. Merchea
concluded that there was no difference in acute
inflammatory response with the extent of contact
lens solution-associated staining. The absence of a
difference in inflammatory response suggests that
contact lens solution-associated transient corneal
staining is not related to tissue damage.
‘Introducing the New Experience in Comfort and
Vision’ enticed delegates to the Bausch & Lomb
Platinum Sponsor’s showcase for a ‘lunch and
learn’. The session was delivered by Professor Joe
Barr, Vice President of Global R&D Vision Care and
Dr Gerard Cairns, Manager of Clinical and Scientific
Affairs. Attendees were given information about
the new addition to the SofLens™ daily disposable
family - SofLens™ daily disposable for Astigmatism.
17
SofLens™ daily disposable for Astigmatism will
deliver complete visual performance and all day
comfort that your patients deserve. Delegates
who attended this ‘lunch & learn’ were invited to
register their interest in working with this lens as
early as late summer.
Besides the clinical side of the Conference, the
BCLA is also a great opportunity to meet up with
colleagues old and new at the numerous social
events that are on offer. Keeping to the ‘hot
quartet ‘Siren’ while tempting red and green
cocktails were offered to guests to celebrate the
steps the industry is taking in raising the
awareness of patient compliance.
In the exhibitors’ hall Bausch & Lomb’s new stand
literally lit-up the hall; showcasing the vision care
lenses PureVision™ and SofLens™ daily disposable
and lens care offerings including the introduction
of ReNu® MultiPlus alongside ReNu® MPS and the
new and improved EasySept®.
Recently published market data reveals that
during the beginning of 2008 37% of all new
soft contact lens fits are daily disposable but
only 10% of these were toric. There is an
obvious opportunity within the daily disposable
toric sector to ensure that practitioners fit more
astigmatic patients the right way.
Barr and Cairns discussed this innovative daily
disposable lens for astigmatic patients. The only
daily disposable toric lens with the Bauch & Lomb
aspheric optics incorporating a bi-aspheric front
surface for enhanced visual quality. This new
addition is to be launched with a comprehensive
range of parameters designed with the eye care
practitioner and patient in mind. Fitting the
topic’ theme of Compliance, our party on
Thursday evening brought Bausch & Lomb’s
message on Compliance to life with traffic lights
and human statues inviting guests to transform
from RED DEVILS into GREEN ANGELS.
Entertainment was provided by the electric string
2009 BCLA Clinical Conference &
Exhibition Manchester, May 28–31, 2009
We hope to see you there!
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 18
BAUSCH & LOMB IN FOCUS
18
®
Stellaris goes mobile!
The Bausch & Lomb Stellaris® Vision Enhancement System empowers
you to exceed patient expectations.
So, it is only appropriate that when we
deliver Stellaris® to you, the same exacting
standards apply!
We would therefore like to introduce you to
Chris Parrock, the new Bausch & Lomb UK
distribution officer, who will be your contact for
all deliveries of both demonstration and newly
purchased equipment. Chris, pictured below
with the new Bausch & Lomb Mercedes van,
represents another step towards our intent to
establish market leadership in exacting
standards of customer service.
Chris will liaise with your IT department in
advance of a delivery to organise all aspects of
installation, including ethernet connection of
your Stellaris®. This connectivity is a feature
unique in enabling pro-active service support
remotely. Real time monitoring of the technical
efficiency of your Stellaris® will allow
preventative maintenance to be optimised,
increasing the efficiency of your investment.
Your Stellaris® will be delivered directly to you
by Chris in its bespoke and manoeuvrable
carrying case, allowing installation of your new
equipment directly into theatres. He will liaise
with both Electrical Physics and Central Sterile
Services to ensure all checks and preparations
for the use of Stellaris® are completed well
ahead of the first surgery. All start-up
consumables will also be delivered by him,
ensuring a smooth transition to demonstration
or installation of your new phaco machine.
Designed in conjunction with leading
cataract surgeons from around the
world, the Stellaris Vision Enhancement
System delivers fluidics and power for
exceptional safety, surgical efficiency
and ergonomic advances that make
both biaxial and coaxial MICS™
techniques easier.
®
Chris will ensure continuity and co-ordination
behind the scenes by linking directly with
customer services, sales and technical service.
To further enhance our service to you, he will
provide a direct link from our central service
warehouse to any point in the UK allowing for
reduced down-time during both cataract and
refractive service emergencies.
Chris is a fully qualified fitness instructor and
applies exacting standards to both his personal
appearance and efficiency. He takes great pride
in the image he portrays for Bausch & Lomb,
and we are sure you will benefit from his
motivation, drive and attention to detail.
Chris can be contacted via the customer
service team on 020 8781 0000.
Chris Parrock, Distribution Officer
EQ Fluidics provides an unprecedented
balance of aspiration dynamics in flow
and vacuum modes for exceptional
chamber stability – empowering safety.
Efficient cutting and optimised
cavitation enables rapid nucleus
emulsification and removal of nucleus
material – empowering efficiency.
Advanced ergonomics deliver
unsurpassed control, comfort and
convenience – empowering ease of use.
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:02
Page 19
CONGRESS/NEWS
19
Events diary
Bausch & Lomb are proud to be a sponsor of BEAVRS 2008
BEAVRS 2008
26, 27 and 28 November 2008
Bausch & Lomb are proud to be a sponsor of BEAVRS 2008
Thames Valley BEAVRS at Reading, Berkshire
New Horizons in VR Nursing
An inaugural meeting for VR Nurses
Date: Wednesday, 26th November 2008 • Venue: Wakefield Park, Reading
Key Note Speaker - Isabella Hamilton Bower from Moorfileds Hospital
Registration Fee
£120.00
Topics include:
* Early Bird Special *
•
•
•
•
•
Register before Friday,
26th September and
enjoy the reduced fee of
AMD Service
Role of the VR Nurse
23GA the future
Day case service
Single use instrumentation and many more....
£95.00
Registration forms and more information available on www.beavrs2008.org or call Joanna Foster on 020 7737 6602
CONGRESS DATES 2008
July 5–6, 2008
BSRS
Oxford, UK
November 8–11, 2008
AAO
Atlanta, USA
July 7–9, 2008
Oxford Congress
Randolph Hotel
Oxford, UK
November 13–14, 2008
UKISCRS
Brighton, UK
September 13–17, 2008
XXVI ESCRS Congress
Berlin, GERMANY
September 19–21, 2008
ABDO Conference
Mercure Holland House Hotel
Cardiff, UK
November 27–28, 2008
BEAVRS Meeting
Reading, UK
December 8–9, 2008
Moorfields Ophthalmology
Course for General Practitioners
Institute of Child Health
London, UK
HOW TO CONTACT YOUR LOCAL SALES REPRESENTATIVE
VIA THE CUSTOMER SERVICE TEAM
REFRACTIVE DIVISION
Laser Eye Correction
Monday to Friday
8.00 am - 5.30 pm
Telephone 020 8781 0000
CATARACT DIVISION
Cataract
Vitreo Retinal
Ophthalmic Instruments
Monday to Friday
8.00 am - 5.30 pm
Telephone 020 8781 0000
PHARMACEUTICAL DIVISION
Pharmaceuticals
Dry Eye Relief
Eye Health Supplements
Monday to Friday
8.00 am - 5.30 pm
Telephone 020 8781 2991
VISION CARE DIVISION
Contact Lenses
Lens Care
Monday to Friday
9.00 am - 5.30 pm
Saturday
9.00 am - 2.00 pm
Telephone 0845 6022350
B+L Newsletter 2nd edition:Layout 1
1/7/08
17:01
Page 1000
Coming up in the autumn issue...
The ultimate wavefront-guided solution
The Bausch & Lomb story - a history of innovation
Fitting more astigmatic patients in the right way
“Have your say”
Your opinion is greatly valued…
Do you have an interesting topical news story to tell,
or a worthy article that you would like to share with the
rest of the readers. We would very much like to hear from you,
please send your letters (including your full name, email,
postal address and postcode) to Jill Collishaw, Visions Editor at:
jill.collishaw@bausch.com or by post using the address below.
www.bausch.co.uk
™ and ® denotes trademark and registration mark of Bausch & Lomb Incorporated.
© Copyright 2008 Bausch & Lomb Incorporated. All rights reserved.
BLNLSM-1/2008 Date of preparation June 2008
Bausch & Lomb Incorporated
Bausch & Lomb House
106 London Road
Kingston-upon-Thames
Surrey, KT2 6TN, UK
Tel:
020 8781 2900
Fax:
020 8781 2901
Website: www.bausch.co.uk